A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Hematologic Malignancies
Related studies linked through entity extraction aliases.
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells
- Status
- WITHDRAWN
- Phase
- N/A
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies
- Status
- TERMINATED
- Phase
- NA
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia
- Status
- COMPLETED
- Phase
- PHASE1
Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders
- Status
- UNKNOWN
- Phase
- N/A
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Adult Double Cord Blood Transplant Study
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase II Trial of Pentostatin and Targeted Busulfan
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies
- Status
- COMPLETED
- Phase
- PHASE2